BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17673142)

  • 1. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors, inflammation and cancer.
    Tsan MF
    Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like receptors (TLRs) and their ligands.
    Uematsu S; Akira S
    Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors as targets for inflammation, development and repair in the central nervous system.
    van Noort JM
    Curr Opin Investig Drugs; 2007 Jan; 8(1):60-5. PubMed ID: 17263186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of toll-like receptors in human diseases.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral recognition by Toll-like receptors.
    Barton GM
    Semin Immunol; 2007 Feb; 19(1):33-40. PubMed ID: 17336545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H; Barrat FJ; Hessel EM; Coffman RL
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
    Fleer A; Krediet TG
    Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
    Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
    J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of Toll-like receptors in bacterial infections?
    Gerold G; Zychlinsky A; de Diego JL
    Semin Immunol; 2007 Feb; 19(1):41-7. PubMed ID: 17280841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of toll-like receptors at the maternal-fetal interface.
    Koga K; Mor G
    Reprod Sci; 2008 Apr; 15(3):231-42. PubMed ID: 18421019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of endogenous triggers on trauma-associated inflammation.
    Zedler S; Faist E
    Curr Opin Crit Care; 2006 Dec; 12(6):595-601. PubMed ID: 17077693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
    Skivka LM; Pozur VV
    Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.